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Background: The spleen is an active lymphoid organ. The effect of splenectomy on the immune response remains
unclear. This study investigated whether splenectomy can induce immune tolerance and has a beneficial role in
cardiac allograft.
Methods: Wistar rats were used for heart donors. The Sprague–Dawley (SD) rats designated as the recipients of
heart transplantation (HT) were randomly assigned into four groups: sham, splenectomy, HT, splenectomy + HT. The
survival of transplanted hearts was assessed by daily checking of abdominal palpation. At various time points after
transplantation, the transplanted hearts were collected and histologically examined; the level of CD4
+CD25
+ T
regulatory lymphocytes (Tregs) and rate of lymphocyte apoptosis (annexin-v+ PI+ cells) in the blood were analyzed
by using flow cytometric method.
Results: 1) Splenectomy significantly prolonged the mean survival time of heart allografts (7 ± 1.1 days and 27 ± 1.5 days
for HT and splenectomy + HT, respectively; n = 12-14/group, HT vs. splenectomy +HT, p < 0.001); 2) Splenectomy delayed
pathological changes (inflammatory cell infiltration, myocardial damage) of the transplanted hearts in splenectomy +HT
rats; 3) The level of CD4
+CD25
+ Tregs in the blood of splenectomized rats was significantly increased within 7 days (2.4 ±
0.5%, 4.9 ± 1.3% and 5.3 ± 1.0% for sham, splenectomy and splenectomy +HT, respectively; n = 15/group, sham vs.
splenectomy or splenectomy +HT, p < 0.05) after splenectomy surgery and gradually decreased to baseline level; 4)
Splenectomy increased the rate of lymphocyte apoptosis (day 7: 0.3 ± 0.05%, 3.9 ± 0.9% and 4.1 ± 0.9% for sham,
splenectomy and splenectomy +HT, respectively; n = 15/group, sham vs. splenectomy or splenectomy +HT, p < 0.05) in a
pattern similar to the change of the CD4
+CD25
+ Tregs in the blood.
Conclusions: Splenectomy inhibits the development of pathology and prolongs the survival time of cardiac allograft. The
responsible mechanism is associated with induction of immune tolerance via elevating CD4
+CD25
+ Tregs and increasing
lymphocyte apoptosis.
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Cardiac transplantation is the preferred surgical therapy
for patients with end-stage heart diseases. However, allo-
graft rejection is the major challenge for the transplant-
ation [1]. To date, several strategies have been made
towards preservation of the transplanted heart by regulat-
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reproduction in any medium, provided the oradministration of immunosuppressive drugs [2] and gen-
eration of tolerogenic dendritic cells [3]. Nevertheless, the
obstacle such as the adverse effects jeopardizes the clinical
application [4]. Therefore, new avenues are demanded for
successful cardiac transplantation.
Transplant immune tolerance is defined as a lack of
transplant rejection in the recipient in the absence of im-
munosuppressive agents. CD4+CD25+ Tregs are a minor
subset (5 - 10%) of CD4+ T cells, arising in the thymus.
Accumulating data showed that the CD4+CD25+ Tregs
potentially contribute to the development of transplant
immune tolerance. For example, Sakaguchi and colleagues. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mice reduced the survival of the grafts [5]. Graca et al. [6]
demonstrated that CD4+CD25+ Tregs are the principle
regulator of transplantation tolerance by suppressing the
active T cells.
The spleen is the largest single lymphoid organ in the
body. It plays a critical role in the immune response.
Several studies have investigated the effects of splenec-
tomy on the immune system. Thomas et al. [7] showed
that splenectomy prevented the hyperacute rejection of
rabbit renal allograft. Carobbi and colleagues [8] found
that splenectomy increased the survival rate of cardiac
xenograft by blocking the humoral antibody response.
However, the effect of splenectomy on immune toler-
ance of cardiac transplantation remains unclear.
The objective of this study was to determine whether
splenectomy can increase the survive time of heart allo-
graft by developing immune tolerance via augmenting
Tregs and increasing lymphocyte apoptosis.
Methods
Animals
Adult Wistar and Sprague–Dawley (SD) rats (weight,
250 - 300 g) were used as donors and recipients, respect-
ively. All rats were purchased from the Medical Experi-
mental Animal Center of Sun Yat-sen University and
housed in the animal care facility at Sun Yat-sen Univer-
sity. All rats were kept under standard temperature, hu-
midity, and time light conditions and fed standard chow
and water ad libitum. All experimental protocols were
reviewed and approved by the Institutional Animal Care
and Use Committee of Sun Yat-sen University.
Experiment groups
All SD rats were randomly assigned to four groups
(n = 15/group): sham; splenectomy; HT; splenectomy +HT.
Splenectomy and heterotopic heart transplantation
In the sham group, the SD rats underwent laparotomy
only. In splenectomy and splenectomy +HT groups, the
splenectomy surgery was performed according to a pre-
vious published method [9]. Briefly, the rats were
anaesthetized by a single intraperitoneal injection of
ketamine/xylazine (100:10 μg/kg). After the spleen was
surgically exposed and Hilar vessels were clamped, the
spleen was removed and the vessel stump was ligated
with suture. In HT and splenectomy +HT groups, hearts
from Wistar rats (donors) were transplanted into SD rats
(recipients) as previously reported with slight modifica-
tions [10-12]. In brief, the SD rats were anaesthetized as
above described. A midline incision was made on the ab-
dominal wall. By using standard vascular microsurgical
techniques, the recipient’s abdominal aorta was anasto-
mosed end-to-side to the donor’s abdominal aorta andthe recipient’s inferior vena cava was anastomosed to the
donor’s pulmonary artery. Graft survival was monitored
by daily checking of palpable heartbeat. Graft rejection
was defined as the cessation of heartbeat.
Isolation of mononuclear cells from peripheral blood
A volume of 0.3-0.5 ml of peripheral blood was taken
into a sterile heparinized syringe from the caudal vein of
the SD rats in sham, splenectomy, and splenectomy +
HT groups at various time points (day 1, 3, 5, 7, 15, 20,
and 28) after sham or splenectomy surgery, or from the
SD rats in HT group at day 1, 3, 5, and 7 after HT trans-
plantation surgery. The peripheral blood mononuclear
cells (PBMCs) were prepared by gradient density centri-
fugation as we described previously with slight modifica-
tions [13]. Briefly, blood was diluted in 2 ml PBS and
then gently layered over equal volume of gradient
medium (Hisopaque-1083, Sigma, Fairfax, VA) for cen-
trifugation at 800 g for 30 mins at 4°C. The PBMCs in
the interface layer were transferred to a new tube,
washed with PBS, centrifuged at 400 g for 5 mins at 4°C
and used for flow cytometric analysis.
Analysis of CD4+CD25+ Tregs by flow cytometry
The Tregs were identified by double positive expression
of membrane specific markers CD4 and CD25. The per-
centage of CD4+CD25+ Tregs in the peripheral blood
from all experiment groups was analyzed at different
time points (day 1, 3, 5, 7, 15, 20, and 28). The PBMCs
were collected as described above and resuspended with
PBS and incubated with FITC-conjugated anti-rat CD4
(eBioscience, San Diego, CA) and PE-conjugated anti-rat
CD25 (eBioscience, San Diego, CA) antibodies for 30
mins at 4°C in the dark. Isotype matched (IgG) non-
specific antibodies served as negative controls. The con-
centrations of antibodies were applied according to
manufacture instructions. A total of at least 10 000
events were collected and analyzed by using Accuri C6
flow cytometer and CFlow Plus Analysis software (Ann
Arbor, MI). A live lymphocyte gate was created on dot
plots using forward scatter and side scatter plots. The
percentage of Tregs was determined within the settled
gate by double positive staining of CD4 and CD25.
Analysis of lymphocyte apoptosis by flow cytometry
At different time points (day 1, 3, 5, 7, 15, 20, and 28),
the PBMCs were collected from all experimental groups
as described above to assess lymphocyte apoptosis.
Apoptosis was measured by detecting phosphatidylserine
externalization in the cell membrane using the annexin-
v/propidium iodide (PI) assay. In brief, the collected cells
were washed twice with cold PBS, centrifuged,
resuspended in 100 μl of binding buffer containing 5 μl
FITC-conjugated annexin-v (Invitrogen, Carlsbad, CA)
Figure 1 Heterotopic heart transplantation surgery.
Representative images show: A, the abdominal aorta and inferior
vena cava of a SD rat; B, the heart ready for transplantation; C, a SD
rat with a transplanted heart; D, detecting heartbeat of transplanted
heart by palpation.
Figure 2 Assessment the mean survival time of cardiac
allograft. The Kaplan–Meier curve shows the survival time of
transplanted hearts. The mean allograft survival time was
significantly prolonged in splenectomy + HT group (—) when
compared with cardiac allograft alone rats in HT group (− −) (7 ± 1.1 days
and 27± 1.5 days for HT and splenectomy+HT, n = 12-14/group, HT vs.
splenectomy+HT, p < 0.001).
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bated for 15 mins at room temperature in the dark. Isotype
matched (IgG) non-specific antibodies served as negative
controls. The concentrations of antibodies were applied
according to manufacture instructions. A total of at least
10 000 events were collected and analyzed by using Accuri
C6 flow cytometer and CFlow Plus Analysis software (Ann
Arbor, MI). A live lymphocyte gate was created on dot
plots using forward scatter and side scatter plots. The rate
of lymphocyte apoptosis was determined within the settled
gate by double positive staining of annexin-v and PI.
Histological examination of heart
The heart samples were collected from either splenec-
tomy group or splenectomy + HT group. The heart sam-
ples harvested from donor rats served as the control
group. All tissue samples were fixed in 4% buffered for-
malin solution overnight, embedded in paraffin, sec-
tioned (5–6 μm thickness) under a microtome, and
stained with hematoxylin and eosin (H&E) by using the
standard method. All samples were analyzed under light
microscopy in a blinded fashion.
Statistical analysis
Data were expressed as mean ± SEM. Means for two
groups were compared using Student’s t-test. Multiple
comparisons were performed by one-way ANOVA. Graft
survival was plotted using Kaplan-Meier method, and allo-
graft survival rates were analyzed by using the log-rank
test. P values <0.05 were considered statistically significant.
Results
Splenectomy prolongs the mean survival time of heart
allografts
The representative images of heart transplantation are
presented in Figure 1. The survival time of transplanted
hearts in HT group was 7 ± 1.1 days (n = 12), while the
survival time of transplanted hearts in splenectomy +
HT group was 27 ± 1.5 days (n = 14). The data showed
that the mean survival time of heart allograft in
splenectomized rats was significantly longer (P < 0.001)
than that in non-splenectomy rats (Figure 2).
The level of CD4+ CD25+ Tregs was increased in
splenectomized rats
The CD4+CD25+ Tregs in the PBMCs were determined by
using the flow cytometry method. In the forward and side
scatter plots, the typical lymphocyte population identified
on basis of size and granularity was presented and a gate
(R1) was set (Figure 3A). Representative flow cytometric
panels showed the percentage of CD4+CD25+ Tregs within
the gate (R1) in all experimental groups (Figure 3B-E) at
day 5 after transplantation. We observed that there was a
higher percentage of CD4+CD25+ Tregs (present in theupper right of the quarternary plot) in splenectomy and
splenectomy +HTgroups at day 5. Flow cytometric analysis
revealed that the percentage of CD4+CD25+ Tregs was in-
creased on day 3, 5, and 7 after splenectomy surgery (day 7:
2.4 ± 0.5%, 4.9 ± 1.3% and 5.3 ± 1.0% for sham, splenectomy
and splenectomy +HT, respectively; n = 15/group, sham vs.
splenectomy or splenectomy +HT, p < 0.05). Then, the level
of CD4+CD25+ Tregs in recipient rats was gradually de-
creased to baseline level on day 28 (2.4 ± 0.5%, 2.4 ± 0.5%
and 2.5 ± 0.5% for sham, splenectomy and splenectomy +
Figure 3 Analysis of the level of CD4+CD25+ Tregs by flow cytometry. Representative flow cytometric plots: A, the dot plot shows the
typical location of lymphocyte population and its gate (R1); B-E, the quandary plots demonstrates the level of CD4+CD25+ Tregs at day 5 after
transplantation of all experimental groups; F, summarized data were expressed as mean ± SEM, n = 5-15/group, *p < 0.05, vs. sham; # p < 0.05, vs.
HT; + p < 0.05, vs. splenectomy at day 1 or day 28; & p < 0.05, vs. splenectomy + HT at day 1 or day 28.
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splenectomy +HT, p > 0.05). There were neither significant
differences in the levels of CD4+CD25+ Tregs between
sham and HT groups, nor between splenectomy and splen-
ectomy +HT groups, indicating heart transplantation alone
had no effect on the CD4+CD25+ Tregs level. These data
were summarized in Figure 3F.The lymphocyte apoptotic rate was increased in
splenectomized rats
In all experimental groups, the apoptotic rate in lympho-
cytes was analyzed by the flow cytometry method. In the
forward and side scatter plots, the typical lymphocyte
population identified on basis of size and granularity
was presented and a gate (R3) was set (Figure 4A).
Figure 4 Analysis of the lymphocyte apoptotic rate by flow cytometry. Representative flow cytometric plots: A, the dot plot shows the
typical location of lymphocyte population and its gate (R3); B-E, the quandary plots demonstrates the percentage of lymphocyte apoptosis at day
7 after transplantation of all experimental groups; F, summarized data were expressed as mean ± SEM, n = 5–15/group, *p < 0.05, vs. sham;
# p < 0.05, vs. HT; + p < 0.05, vs. splenectomy at day 1 or day 3 or day 28; & p < 0.05, vs. splenectomy + HT at day 1 or day 3 or day 28.
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rate of lymphocyte apoptosis within the gate (R3) in all
experimental groups (Figure 4B - E) at day 7 after heart
transplantation. We found that there was a higher rate
of lymphocyte apoptosis (present in the upper right of
the quarternary plot) in splenectomy and splenectomy +
HT groups at day 7. Flow cytometric analysis revealedthat the percentage of annexin-v+ PI+ expression cells
was increased on day 3, 5, and 7 after the splenectomy
surgery (day 7: 0.3 ± 0.05%, 3.9 ± 0.9% and 4.1 ± 0.9%
for sham, splenectomy and splenectomy + HT, respect-
ively; n = 15/group, sham vs. splenectomy or splenec-
tomy + HT, p < 0.05). Then, the lymphocyte apoptotic
rate was gradually decreased to baseline level in
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0.3 ± 0.01% for sham, splenectomy and splenectomy +HT,
respectively; n = 5/group, sham vs. splenectomy or splen-
ectomy +HT, p > 0.05). There were neither significant
differences in the percentages of annexin-v+ PI+ cells
between sham and HT groups, nor between splenectomy
and splenectomy +HT groups, indicating heart trans-
plantation alone had no effect on lymphocyte apoptosis.
These data were summarized in Figure 4F.
Pathological changes of transplanted hearts
The histopathology of heart allografts were assessed at
different time points (day 3, 5, 7, 15, and 28) in HT and
splenectomy +HT groups. Figure 5A shows the histology
of a normal rat heart. At day 3, the transplanted hearts
from HT group (Figure 5B) had interstitial edema and in-
flammatory cell infiltration, which were absent in the allo-
graft hearts from splenectomy +HT group (Figure 5E). At
day 5, cardiomyocyte hemorrhage and an increasing num-
ber of inflammatory cell infiltrations were found in the
transplanted hearts in HT group (Figure 5C). No patho-
logic change could be identified in the transplanted hearts
from splenectomy +HT group (Figure 5F). At day 7,Figure 5 Histological assessment of transplanted hearts. Representativ
from a donor rat showing the normal structure of cardiac myofibers; B-D, h
interstitial edema and inflammatory cell infiltration were observed on day 3
number of inflammatory cell infiltrations were found on day 5 after transpl
destruction of myofibers were observed on day 7 after transplantation; E-I,
time point; E-F, no pathology changes could be observed on days 3 and 5
was seen in the myocardium on day 7 after transplantation; H, cardiomyoc
could be observed on day 15 after transplantation; I, myocardial cell necro
after transplantation.indications of severe rejections such as diffuse inflamma-
tory infiltrate, myocardial cell necrosis, and destruction of
myofibers appeared in the transplanted hearts from HT
(Figure 5D), while there was mild cell infiltration in the
myocardium of the allograft hearts from splenectomy +
HT group (Figure 5G). At day 15, interstitial edema and
increased inflammatory cell infiltration were observed in
the allograft hearts collected from splenectomy +HT
group (Figure 5H). At day 28, the transplanted hearts col-
lected from splenectomy +HT group were soft and par-
tially gray-white with focal edema in the subepicardium.
Upon examination with a microscope, severe rejection of
the transplanted hearts showed myocardial cell necrosis
and destruction of myofibers (Figure 5I).
Discussion
The major finding of the present study is that splenec-
tomy can suppress the development of pathology and
prolong the mean survival time of the cardiac allograft.
Our data suggested that splenectomy plays a critical role
in the development of immune tolerance in heart trans-
plantation by increasing the level of CD4
+CD25
+ Tregs
and promoting the apoptosis of lymphocytes.e images of H&E staining (all magnifications: 20x): A, a heart section
eart sections collected from HT group at different time point; B,
after transplantation; C, cardiomyocyte hemorrhage and an increasing
antation; D, diffuse inflammatory infiltrate, myocardial cell necrosis, and
heart sections collected from splenectomy + HT group at different
after transplantation; G, mild interstitial edema and cellular infiltration
yte interstitial edema and an increasing inflammatory cell infiltration
sis and destruction of myofibers were observed on day 28
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of transplant failure. As we know, the largest lymphatic
organ, the spleen, provides an immune microenviron-
ment which accepts antigen stimulation and causes an
immune response. Therefore, splenectomy is able to
eliminate a primary immune response to an allograft. An
earlier study [8] has reported that splenectomy is benefi-
cial for xenograft survival by blocking the humoral anti-
body response.
The CD4+CD25+ Tregs, which constitute 5 - 10% of
peripheral CD4+ T cells in mice and humans, are recog-
nized as a major subset of immune cells possessing
potent suppressive properties [14,15]. A study on a
thymectomised mouse model showed that CD4+CD25+
Tregs can prevent autoimmunity and allergy [16]. More-
over, several transplantation studies [7,8] have demon-
strated that CD4
+CD25
+ Tregs can effectively prevent
transplantation rejection by blocking the initiation of the
immune response against the graft and actively partici-
pating in the regulation of the immune tolerance. In
consistence with those reports, we found that the level
of CD4
+CD25
+ Tregs was significantly elevated within
the first 7 days after the splenectomy surgery and grad-
ually decreased to the baseline level, and the histopatho-
logic change of transplanted hearts was milder and the
mean survival time of transplanted hearts was longer in
splenectomized rats. The possible explanation of this
phenomenon was that accumulation of CD4
+CD25
+
Tregs inhibited the activation of naive T cells of the re-
cipient, creating a permissive environment for graft
acceptance. That is why CD4
+CD25
+ Tregs were in-
creased in the early days (within 7 days) after the splen-
ectomy. However, due to some of the CD4
+CD25
+ Tregs
being generated from the CD4
+CD25 - population in the
adoptive system in the spleen [17,18], the CD4
+CD25 -
population was decreased after the splenectomy, which
could explain why the CD4
+CD25
+ Tregs were gradually
back to the normal level later.
The mechanisms responsible for CD4
+CD25
+ Tregs im-
munity suppression are not fully understood, and many of
these mechanisms remain controversial [6,19]. Some ob-
servations have shown that one of the immunesuppression
mechanisms was CD4
+CD25
+ Tregs induced apoptosis of
the immune cells [20-24]. Since lymphocyte apoptosis is an
important immunoregulatory mechanism for maintaining
homeostasis in the immune system in vivo [25-27], which
could be an effective strategy to reduce transplantation re-
jection. Sharland et al. [28] reported that tolerant rats had
higher numbers of apoptotic activated T cells in a liver
transplantation model. In this study, we found that splen-
ectomy regulated the immune homeostasis in vivo by in-
creasing the rate of lymphocyte apoptosis. The flow
cytometric results demonstrated that the rate of lympho-
cyte apoptosis was significantly increased in thesplenectomized rats within the first 7 days after the splen-
ectomy surgery and gradually decreased to baseline level.
At the same time, this increased apoptosis tendency
paralleled the raised level of CD4
+CD25
+ Tregs. These data
are in agreement with the previous findings [21-23,28].
In this study, we first reported that splenectomy
prolonged the survival time of cardiac allograft by en-
hancing the immune tolerance via raising the level of
CD4
+CD25
+ Tregs and increasing the apoptotic rate of
lymphocyte. The spleen has several unique functions in
the immune system concerning not only the CD4
+CD25
+
Tregs, but also various kinds of cytokines such as
interleukin-10 and transforming growth factor (TGF)-β.
Our future study on these cytokines will better ascertain
the immunomodulatory role of splenectomy in the car-
diac allograft.
Conclusions
Our data indicate that splenectomy inhibits the develop-
ment of pathology and prolongs the survival time of car-
diac allograft. The responsible mechanism is associated
with the induction of immune tolerance via elevating
CD4
+CD25
+ Tregs and increasing lymphocyte apoptosis.
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